AKARI THERAPEUTICS PLC-ADR (AKTX)
US00972G2075 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -10.01M | -17.75M | -17.42M | -17.08M | -17.11M | |||
| Depreciation Amortization | 4.00K | 0.00 | 0.00 | 10.00K | 20.00K | |||
| Change In Working Capital | -866.00K | 820.00K | -1.98M | -60.00K | 3.09M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | -5.56M | -4.58M | 560.00K | 180.00K | 1.08M | |||
| OPERATING CASH FLOW | -16.43M | -21.50M | -18.85M | -16.95M | -12.92M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | N/A | N/A | N/A | N/A | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 7.02M | 25.29M | 14.29M | 25.07M | 12.65M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 7.02M | 25.29M | 14.29M | 25.07M | 12.65M | |||
| Exchange Rate Effect | 7.00K | 110.00K | -140.00K | 200.00K | 30.00K | |||
| CHANGE IN CASH | -9.40M | 3.89M | -4.69M | 8.32M | -240.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -16.43M | -21.50M | -18.85M | -16.95M | -12.92M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | 0.00 | |||
| FREE CASH FLOW | -16.43M | -21.50M | -18.85M | -16.95M | -12.92M | |||
All data in USD